UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010831
Receipt number R000012684
Scientific Title Effects of hypnotic on continuous positive airway pressure adherence
Date of disclosure of the study information 2013/05/31
Last modified on 2016/05/05 12:02:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of hypnotic on continuous positive airway pressure adherence

Acronym

Hypnotice and CPAP adherence

Scientific Title

Effects of hypnotic on continuous positive airway pressure adherence

Scientific Title:Acronym

Hypnotice and CPAP adherence

Region

Japan


Condition

Condition

Sleep apnea syndrome

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether hypnotic (Eszopiclone) improves CPAP adherence in sleep apnea syndrome with initial CPAP
intolerance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

average duration of CPAP usage for 4 weeks after the start of hypnotic

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of Eszopiclone

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) severe sleep apnea syndrome (AHI->20)
2) being treated by CPAP
3) CPAP intolerance

Key exclusion criteria

1) patients who are prohibited to take Eszpiclone
2) patients without informed consent
3) patients with severe hypoxemia at night
4) patients on psychiatric medication
5) patients with untreated nasal diseases such as deviation of nasal septum

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaoru Ogawa

Organization

Keio University School of Medicine

Division name

Otolaryngology- head and neck surgery

Zip code


Address

35 Shinanomachi, Shinjuku

TEL

0353633827

Email

oishin@keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Oishi

Organization

Keio University School of Medicine

Division name

Department of otolaryngology

Zip code


Address

35 Shinanomachi, Shinjuku-ku, Tokyo 1608582

TEL

0353633827

Homepage URL

http://www.ccr.med.keio.ac.jp/rinri/index.html

Email

oishin@keio.jp


Sponsor or person

Institute

Keio University School of Medicine, Department of Otolaryngology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 03 Month 25 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 05 Month 29 Day

Last modified on

2016 Year 05 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012684


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name